Examining a paradox in the pathogenesis of human pulmonary tuberculosis: immune activation and suppression/anergy (Q39553401)

13 September 2017

1 reference

title

Examining a paradox in the pathogenesis of human pulmonary tuberculosis: immune activation and suppression/anergy (English)

1 reference

ORCID Public Data File 2021

13 September 2017

0 references

pulmonary tuberculosis

1 reference

1 reference

author name string

Vanham G

1

1 reference

13 September 2017

Toossi Z

2

1 reference

13 September 2017

Hirsch CS

3

1 reference

13 September 2017

Wallis RS

4

1 reference

13 September 2017

Schwander SK

5

1 reference

13 September 2017

Rich EA

6

1 reference

13 September 2017

Ellner JJ

7

1 reference

13 September 2017

1 January 1997

1 reference

Tubercle and lung disease

13 September 2017

1 reference

13 September 2017

78

1 reference

13 September 2017

3-4

1 reference

13 September 2017

145-158

1 reference

The pathogenesis of tuberculosis

13 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Review: the immune response in human tuberculosis--implications for tuberculosis control

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Recombinant cytokines for controlling mycobacterial infections

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

The role of cytokines in the immune response to tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

The influence of human immunodeficiency virus infection on tuberculosis in Kampala, Uganda

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Tuberculosis in patients with HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Recognition of a lipid antigen by CD1-restricted alpha beta+ T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Enhancement Of Intracellular Growth Of Mycobacterium Tuberculosis In Human Monocytes by Transforming Growth Factor- l

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Humoral and cellular immunity in the anergic tuberculosis patient. A prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Serum immunoglobulin levels in patients with active pulmonary tuberculosis and patients with Klebsiella infection

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Cytokines and tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Generalized immune activation in pulmonary tuberculosis: co-activation with HIV infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Defective interleukin 2 production and responsiveness in human pulmonary tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Defective gamma-interferon production in peripheral blood leukocytes of patients with acute tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Soluble interleukin-2 receptor in sera of patients with pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Recombinant human interleukin-2 reverses in vitro-deficient cell-mediated immune responses to tuberculin purified protein derivative by lymphocytes of tuberculous patients

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Clinical correlates of interferon gamma production in patients with tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Augmentation of selective monocyte functions in tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Production of tumor necrosis factor alpha by monocytes from patients with pulmonary tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Effect of mycobacteria on sensitivity to the cytotoxic effects of tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Increased expression and occupancy of receptors for tumour necrosis factor on blood monocytes from tuberculosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Influence of tuberculosis on human immunodeficiency virus (HIV-1): enhanced cytokine expression and elevated beta 2-microglobulin in HIV-1-associated tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Expression of functional interleukin 2 receptors by peripheral blood monocytes from patients with active pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Association of Altered Dynamics of Monocyte Surface Expression of Human Leukocyte Antigen DR with Immunosuppression in Tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Increased proportions of peripheral blood gamma delta T cells in patients with pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Gamma/delta T lymphocytes in Mycobacterium tuberculosis infection

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

CD4 cell counts in human immunodeficiency virus-negative patients with tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Cellular immunity in current active pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Cytokine gene activation and modified responsiveness to interleukin-2 in the blood of tuberculosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Cytokine gene expression profile of circulating CD4+ T cells in active pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Expression of tumor necrosis factor in vitro by human mononuclear phagocytes stimulated with whole Mycobacterium bovis BCG and mycobacterial antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

The effect of cytokines on the expression and function of Fc receptors for IgG on human myeloid cells

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Mechanisms underlying immunosuppression induced by Trypanosoma cruzi

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Subset markers of CD8(+) cells and their relation to enhanced cytotoxic T-cell activity during human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Selective increase of activation antigens HLA-DR and CD38 on CD4+ CD45RO+ T lymphocytes during HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Expression patterns of Fc gamma receptors, HLA-DR and selected adhesion molecules on monocytes from normal and HIV-infected individuals.

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Frequency of tuberculin-reactive T-lymphocytes in pleural fluid and blood from patients with tuberculous pleurisy

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Dendritic cell presentation of PPD and 19 kDa protein of Mycobacterium tuberculosis and emergent T helper cell phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Bacillus Calmette-Guérin mycobacteria stimulate human blood dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Sequestration from immune CD4+ T cells of mycobacteria growing in human macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Defective antigen presentation by Mycobacterium tuberculosis-infected monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Suppression of lymphocyte responses by tuberculous plasma and mycobacterial arabinogalactan. Monocyte dependence and indomethacin reversibility

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Suppression of purified protein derivative-induced interleukin-2 production by interaction of CD16 (Leu 11 reactive) lymphocytes and adherent mononuclear cells in tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Regulation of human T-cell production of interleukin 2 by Leu 11 (CD16) positive large granular lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Immunoregulatory Adherent Cells in Human Tuberculosis: Radiation-Sensitive Antigen-Specific Suppression by Monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Increased numbers of interleukin-12-producing cells in human tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Inflammatory and immunomodulatory roles of TGF-beta.

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Biological properties of interleukin 10.

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Functional characterization of human IL-10.

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Immunogenetic Analysis of Human Tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Regulation of apoptosis in immune cells

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Programmed death of T cells in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Acute Plasmodium falciparum infection is associated with increased percentages of apoptotic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Programmed cell death (apoptosis) and cell survival regulation: relevance to AIDS and cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Differential induction of apoptosis by Fas-Fas ligand interactions in human monocytes and macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Fas and tumor necrosis factor receptor-mediated cell death: similarities and distinctions

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Activation of apoptosis by Apo-2 ligand is independent of FADD but blocked by CrmA.

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Apo-3, a new member of the tumor necrosis factor receptor family, contains a death domain and activates apoptosis and NF-kappa B

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas(Apo-1/CD95)

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL.

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Selective CD4+ T cell deletion after specific activation in HIV-infected individuals; protection by anti-CD28 monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Interleukin 4 (IL-4) or IL-7 prevents the death of resting T cells: stat6 is probably not required for the effect of IL-4

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Local production and localization of transforming growth factor-beta in tuberculous pleurisy

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Interleukin 12 at the site of disease in tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Memory lymphocytes from tuberculous effusions: purified protein derivative (PPD) stimulates accelerated activation marker expression and cell cycle progression.

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Pleural fluid and peripheral blood lymphocyte function in tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Evidence for a Th1-like bronchoalveolar T-cell subset and predominance of interferon-gamma gene activation in pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

T lymphocytic and immature macrophage alveolitis in active pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Phenotypes of lung mononuclear phagocytes in HIV seronegative tuberculosis patients: evidence for new recruitment and cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Antigenic specificity and subset analysis of T cells isolated from the bronchoalveolar lavage and pleural effusion of patients with lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Impact of human immunodeficiency virus type 1 on tuberculosis in rural Haiti

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Macrophage-tropic HIV: critical for AIDS pathogenesis?

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Infection of human monocytes with Mycobacterium tuberculosis enhances human immunodeficiency virus type 1 replication and transmission to T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

A TH1-->TH2 switch is a critical step in the etiology of HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Demonstration of the Th1 to Th2 cytokine shift during the course of HIV-1 infection using cytoplasmic cytokine detection on single cell level by flow cytometry

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Impaired interleukin 12 production in human immunodeficiency virus-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Dysregulation of interleukin 8, interleukin 10, and interleukin 12 release by alveolar macrophages from HIV type 1-infected subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Molecular analysis of decreased interleukin-12 production in persons infected with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Differential production of interleukin 10 during human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Accessory cell function in asymptomatic human immunodeficiency virus-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

T-cell dysfunction in HIV infection: anergy due to defective antigen-presenting cell function?

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Accelerated course of human immunodeficiency virus infection after tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Prognosis in HIV-1 infection predicted by the quantity of virus in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Prospective longitudinal analysis of viral load and surrogate markers in relation to clinical progression in HIV type 1-infected persons

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Serum levels of human immunodeficiency virus type 1 (HIV-1) RNA after seroconversion: a predictor of long-term mortality in HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

HIV-1 tropism and co-receptor use

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Change in coreceptor use correlates with disease progression in HIV-1--infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Human immunodeficiency virus type 1 activation after blood transfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Increased plasma human immunodeficiency virus type 1 burden following antigenic challenge with pneumococcal vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Increased in vitro tetanus-induced production of HIV type 1 following in vivo immunization of HIV type 1-infected individuals with tetanus toxoid

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Macrophages as a source of HIV during opportunistic infections

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Enhanced susceptibility of blood monocytes from patients with pulmonary tuberculosis to productive infection with human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Activation of latent HIV-1 by Mycobacterium tuberculosis and its purified protein derivative in alveolar macrophages from HIV-infected individuals in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Mycobacterium tuberculosis enhances human immunodeficiency virus-1 replication in the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Mycobacterium tuberculosis enhances human immunodeficiency virus-1 replication by transcriptional activation at the long terminal repeat

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

The interferons. Mechanisms of action and clinical applications

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Interferon-gamma and host antimicrobial defense: current and future clinical applications

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Interferon-gamma in the management of infectious diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Prolonged treatment with recombinant interferon gamma induces erythema nodosum leprosum in lepromatous leprosy patients

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Treatment of refractory disseminated nontuberculous mycobacterial infection with interferon gamma. A preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Treatment of multidrug-resistant pulmonary tuberculosis with interferon-gamma via aerosol

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Immunization of healthy adult subjects in the United States with inactivated Mycobacterium vaccae administered in a three-dose series

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Immunotherapy with Mycobacterium vaccae in the treatment of tuberculosis in Romania. 1. Newly-diagnosed pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Immunotherapy with Mycobacterium vaccae in the treatment of tuberculosis in Romania. 2. Chronic or relapsed disease

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Interleukin-12 and its role in the generation of TH1 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

The role of interleukin 12 in the immune response, disease and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Cloning of a new cytokine that induces IFN-gamma production by T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Characterization of interleukin-15 (IL-15) and the IL-15 receptor complex

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Interferon-gamma-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin-12 for interferon-gamma production

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Thalidomide and derivatives: immunological investigations of tumour necrosis factor-alpha (TNF-alpha) inhibition suggest drugs capable of selective gene regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Thalidomide inhibits lipoarabinomannan-induced upregulation of human immunodeficiency virus expression

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Pentoxifylline therapy in human immunodeficiency virus-seropositive persons with tuberculosis: a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

TH1/TH2 switching and loss of CD4+ T cells in chronic infections: an immunoendocrinological hypothesis not exclusive to HIV

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Pharmacologic modulation of Th1- and Th2-associated lymphokine production

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Thalidomide increases the synthesis of IL-2 in cultures of human mononuclear cells stimulated with Concanavalin-A, Staphylococcal enterotoxin A, and purified protein derivative

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Dexamethasone adjunctive treatment for tuberculous meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Randomized controlled trial of dexamethasone in tuberculous meningitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

The effect of thalidomide on the pathogenesis of human immunodeficiency virus type 1 and M. tuberculosis infection

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

A double-blind placebo-controlled phase II trial of thalidomide in asymptomatic HIV-positive patients: clinical tolerance and effect on activation markers and cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Interleukin-15 protects from lethal apoptosis in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-gamma by natural killer cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

Activation of antigen-induced lymphocyte proliferation by interleukin-15 without the mitogenic effect of interleukin-2 that may induce human immunodeficiency virus-1 expression

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2897%2990021-6

7 January 2021

10.1016/S0962-8479(97)90021-6

Identifiers

DOI

1 reference

release_rsgqo3kuofb55eqil6622drcqi

13 September 2017

0 references

1 reference